- Business Wire•4 hours ago
Teva Pharmaceutical Industries Ltd., today announced the launch of generic Pristiq®1 extended-release tablets, 25, 50 and 100 mg, in the U.S.
- Insider Monkey•5 hours ago
An application for a new drug by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been accepted by the Food and Drug Administration. Teva’s drug that is used to treat tardive dyskinesia, SD-809, has also been given priority review. This will allow the drug to be evaluated at a faster rate. “SD-809 has the potential to […]
- Investor's Business Daily•22 hours ago
Teva's woes are set to deepen in 2017 as generic drug prices are projected to topple 7%-10%, Argus analysts said Tuesday.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||35.00 - 35.64|
|52 Week Range||31.90 - 59.35|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||500.71|
|Dividend & Yield||1.36 (3.80%)|
|1y Target Est||N/A|